Parkinson’s disease is a recurrent, recurring condition of the nervous system marked by tremor, postural dysfunction, sluggish movement or bradykinesia, muscle weakness of either body portion, lack of reflex gestures, and often speech trouble. This neurodegenerative disease is caused by the progressive weakening and eventual death of some nerve cells or neurons in the brain that contain the chemical messenger dopamine. Dopamine delivers instructions to the brain’s activity control centre, allowing muscles to function smoothly. Dopamine deficiency causes irregular brain function and the symptoms of Parkinson’s disease. There are various stages of Parkinson’s disease. Stages 1 and 2 describe early stages of Parkinson’s disease with mild symptoms, stages 2 and 3 represent mid-stage symptoms, and stages 4 and 5 represent advanced stages of Parkinson’s disease with extreme crippling symptoms.
Parkinson’s disorder treatment
There is no clear examination for Parkinson’s disease. A synthesis of the patient’s personal records, a study of signs and symptoms, and a neurological and physical assessment is used to identify the condition. There is no prescribed cure for Parkinson’s disease, and each person’s treatment is determined by his or her symptoms. Medication and surgical surgery are two popular therapies. None of the drugs, though, was believed to cure the disease’s symptoms. The main medicine used to cure Parkinson’s disease is levodopa (L-DOPA), which is transformed to dopamine in the body. Aside from medicine and surgery, dietary changes such as physical activity and adequate rest are often advised. Deep brain stimulation has been shown to help certain people with Parkinson’s symptoms.
Parkinson’s disease stem cell treatment
Parkinson’s disorder affects millions of individuals all around the country. Parkinson’s syndrome cannot be cured entirely by conventional therapy. Researchers are looking at how regenerative medicine and stem cell research can be used to cure or avoid the disease. Researchers discovered that dopamine-producing nerve cells can be produced from embryonic stem cells in laboratory rats and later transplanted into the brain to replace lost neurons, which is a significant development for Parkinson’s care. At this time, stem cell therapy for Parkinson’s disease is being explored as an alternative therapeutic choice, giving patients with the disease new hope. A clinical research was reported with the National Institutes of Health at www.clinicaltrials.gov/stemgenex with the aim of evaluating the change of quality of life of Parkinson’s patients after stem cell therapy. The aim of stem cell therapy for Parkinson’s disease is to target the dopamine-producing neurons, which are damaged and lost in the disease. Stem cells can divide into a variety of cell types. Stem cell treatment uses the regenerative capacity of stem cells as well as the production of natural chemicals called cytokines from stem cells to generate fresh dopamine-producing neurons. The production of these neurons results in dopamine release, which restores dopamine functions and thereby reverses Parkinson’s symptoms. Studies have shown that pluripotent stem cells can be used to produce authentic midbrain dopaminergic neurons, and clinical trials involving these cells are in the works.
The cost of a Parkinson’s disease stem cell therapy
The expense of stem cell therapy for Parkinson’s disease is influenced by a number of variables. This involve the patient’s current health status and disease incidence, the type of stem cell required for therapy, the amount of stem cells to be used, the mode of stem cell use, inpatient or outpatient service, hospital brand, operating room, and a variety of other considerations that differ from one person to the next. Mexico is well-known for its treatment centres that specialise in treating Parkinson’s disease with stem cell therapy, with prices beginning at $12,000. India is currently a renowned medical tourism destination. The expense of stem cell therapy for Parkinson’s disease in India ranges from $6800 to $13,000, depending on the disease’s complexity and other variables.